Nobody would be ghoulish enough to delay approval
Post# of 148177
I'm in the camp that the FDA wants the data to justify approval.
Where I fault the FDA is not realizing our MOA made LL a frontrunner back in the spring, at which point they should have helped with money and resources to expedite the trial and get the S/C results in the summer.